Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 114-120

  Mochida, Satoshi ^a   Yoshimoto, Takayuki ^b   Mimura, Sumie ^a   Inao, Mie ^a   Matsui, Atsushi ^a   Ohno, Akihiko ^a   Koh, HeaSaeng ^a   Saitoh, Eiko ^a   Nagoshi, Sumiko ^a   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune hepatitis; Cytotoxic T lymphocytes; Osteopontin; Transgenic mouse

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLOID P COMPONENT; ANTINUCLEAR ANTIBODY; CD8 ANTIGEN; COMPLEMENTARY DNA; CONCANAVALIN A; HLA DR ANTIGEN; OSTEOPONTIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; FEMALE; FERTILIZATION; GENE CONSTRUCT; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER LEVEL; LIVER NECROSIS; LIVER PARENCHYMA; LYMPHOCYTIC INFILTRATION; MALE; MICROINJECTION; MONONUCLEAR CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN CELL; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENES; GENETIC VECTORS; HEPATITIS, AUTOIMMUNE; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NECROSIS; OSTEOPONTIN; SERUM AMYLOID P-COMPONENT; SIALOGLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TISSUE DISTRIBUTION;

MUS MUSCULUS;

EID: 12144289619     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.180     Document Type: Article

References (23)

1. Cerny A., Chisari F.V. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 30:1999;595-601.
2. Ando K., Moriyama T., Guidotti L.G., Wirth S., Schreiber R.D., Schlicht H.J., Huang S.N., Chisari F.V. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1993;1541-1554.
3. Kasahara S., Ando K., Saito K., Sekikawa K., Ito H., Ishikawa T., Ohnishi H., Seishima M., Kakumu S., Moriwaki H. Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J. Virol. 77:2003;2469-2476.
4. Butler W.T. The nature and significance of osteopontin. Connect. Tissue Res. 23:1989;123-136.
5. Uede T., Katagiri Y., Iizuka J., Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol. Immunol. 41:1997;641-648.
6. Kawashima R., Mochida S., Matsui A., YouLuTuZ Y., Ishikawa K., Toshima K., Yamanobe F., Inao M., Ikeda H., Ohno A., Nagoshi S., Uede T., Fujiwara K. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem. Biophys. Res. Commun. 256:1999;527-531.
7. Wang Y., Mochida S., Kawashima R., Inao M., Matsui A., YouLuTuZ Y., Nagoshi S., Uede T., Fujiwara K. Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. J. Gastroenterol. 35:2000;696-701.
8. Singh R.P., Patarca R., Schwartz J., Singh P., Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J. Exp. Med. 71:1990;1931-1942.
9. Murry C.E., Giachelli C.M., Schwartz S.M., Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145:1994;1450-1462.
10. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 287:2000;860-864.
11. Toyonaga T., Hino O., Sugai S., Wakasugi S., Abe K., Shichiri M., Yamamura K. Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc. Natl. Acad. Sci. USA. 91:1994;614-618.
12. Yamamura K., Kikutani H., Takahashi N., Taga T., Akira S., Kawai K., Fukuchi K., Kumahara Y., Honjo T., Kishimoto T. Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J. Biochem. 96:1994;357-363.
13. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
14. Whitehead A.S., Rits M. Characterization of the gene encoding mouse serum amyloid P component: comparison with genes encoding other pentraxins. Biochem. J. 263:1989;25-31.
15. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L.et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 31:1999;929-938.
16. Chiba S., Okamoto H., Kon S., Kimura C., Murakami M., Inobe M., Matsui Y., Sugawara T., Shimizu T., Uede T., Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels. 16:2002;111-117.
17. Isoda K., Nishikawa K., Kamezawa Y., Yoshida M., Kusuhara M., Moroi M., Tada N., Ohsuzu F. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ. Res. 91:2002;77-82.
18. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K.et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:1995;88-91.
19. Kawase Y., Okamoto M., Yokota K., Yoshino K., Yamamura K., Miyazaki J., Young H.A., Oizumi K. IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166:2001;7014-7018.
20. Freude S., Hausmann J., Hofer M., Pham-Mitchell N., Campbell I.L., Staeheli P., Pagenstecher A. Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system. J. Virol. 76:2002;12223-12232.
21. Lassmann S., Kincaid C., Asensio V.C., Campbell I.L. Induction of type 1 immune pathology in the brain following immunization without central nervous system autoantigen in transgenic mice with astrocyte-targeted expression of IL-12. J. Immunol. 167:2001;5485-5493.
22. Holz A., Brett K., Oldstone M.B. Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. J. Clin. Invest. 108:2001;1749-1758.
23. S. Mimura, S. Mochida, M. Inao, A. Matsui, S. Nagoshi, T. Yoshimoto, K. Fujiwara, Massive liver necrosis provoked by imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice, J. Gastroenterol. (in press)